ASO Author Reflections: Predicting High-Risk Oncotype DX Recurrence Scores as a Strategy for Assessing Neoadjuvant Chemotherapy Eligibility.
Overview
publication date
- October 30, 2018
published in
- Annals of surgical oncology Journal
Research
keywords
- Breast Neoplasms
Identity
Scopus Document Identifier
- 85055995277
Digital Object Identifier (DOI)
- 10.1245/s10434-018-6989-1
PubMed ID
- 30377915
Additional Document Info
volume
- 25
issue
- Suppl 3